Medindia

X

Stelara Impresses With Efficacy Data and Dosing Convenience, But Safety Concerns Likely to Impact Near Term Uptake

Thursday, February 18, 2010 General News J E 4
Advertisement

For more information, contact:

BioTrends Research Group, Inc.

Decision Resources, Inc.

Sharon Funk

Christopher Comfort

404-223-2963

781-296-2597

sfunk@bio-trends.com

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
InfraReDx CEO to Discuss Vulnerable Plaque Identif...
S
Vibativ's Delayed Approval for Nosocomial Pneumoni...